论文部分内容阅读
目的 :观察Grave S眼病患者1 31 I治疗前后眼突的变化。方法 :选择经1 31 I治疗 ,半年～ 1年半后 ,治疗结果为正常或甲低 ,有Grave s眼病的 372名患者 ,用眼球突度仪测量治疗前后的眼球突度。结果 :1 31 I治疗前后眼突变化无显著性差异 (P >0 0 5 ) ;1 31 I治疗后甲低患者 ,治疗前后眼突变化有显著性差异 (P <0 0 1)。结论 :1 31 I治疗不导致治疗后眼突恶化 ,早期预防治疗甲低可减少眼突恶化的发生
OBJECTIVE: To observe the changes of the retina of patients with Grave S ophthalmopathy before and after treatment with 131 I. Methods: One hundred and seventy-two patients with Grave’s ophthalmopathy who had been treated with 131 I and a half year to one and a half years after treatment were either normal or hypothyroid. Results: There was no significant difference in the change of ocular process between 131 I treatment before and after treatment (P> 0.05). The change of ocular process before and after treatment of 131 I was lower than that before treatment (P <0.01). Conclusions: 1 31 I treatment does not result in the deterioration of the ophthalm after the treatment, early prevention and treatment of hypothyroidism can reduce the occurrence of ophthalmia